Furthermore, MTX promoted STING pathway activation by inhibiting ENPP1 and provided clinical potential for combining MTX with radiation therapy for the treatment of breast cancer in which ENPP1 shows hyper-expression (Carozza et al., 2020). This evidence concerns the gene STING1 and breast carcinoma.